COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,389 Articles (22,816 medRxiv, 8,573 bioRxiv)

Most recent first Previous |  Page 1719: Articles 17181-17190  | Next

High risk of patient self-inflicted lung injury in COVID-19 with frequently encountered spontaneous breathing patterns: a computational modelling study
Das, A., Weaver, L., Saffaran, S., Yehya, N., Scott, T. E., Chikhani, M., Laffey, J. G., Hardman, J. G., Camporota, L., Bates, D.
10.1101/2021.03.17.21253788 — Posted: 2021-03-17
THE EFFECTIVENESS OF ACB-IP 1.0 UNIVERSAL PATHOGEN FREE CONCENTRATED COCKTAIL CONVALESCENT PLASMA IN COVID-19 INFECTION
Hemsinlioglu, C., Pelit, N. B., Yalcin, K., Gunaydin, O. S., Ozturk Sahin, N., Savas Karagacli, E., Elibol, O., Demir, S. O., Safak, E., Turan, R. D., Celebi, G., Kocaoglu, M. E., Sir Karakus, G., Yurtsever, B., Tastan, C., Abanuz, S., Cakirsoy, D., Dilek Kancagi, D., Torun, Z., Seyis, U., Elek, M., Zengin, R., Kocagoz, A. S., Cuhadaroglu, C., Birgen, N., Ratip, S., Ovali, E.
10.1101/2021.03.05.21251413 — Posted: 2021-03-17
Metagenomic sequencing of municipal wastewater provides a near-complete SARS-CoV-2 genome sequence identified as the B.1.1.7 variant of concern from a Canadian municipality concurrent with an outbreak
Landgraff, C., Wang, L. Y. R., Buchanan, C., Wells, M., Schonfeld, J., Bessonov, K., Ali, J., Robert, E., Nadon, C.
10.1101/2021.03.11.21253409 — Posted: 2021-03-17
Estimating the increased transmissibility of the B.1.1.7 strain over previously circulating strains in England using fractions of GISAID sequences and the distribution of serial intervals
Piantham, C., Ito, K.
10.1101/2021.03.17.21253775 — Posted: 2021-03-17
A feasible and more efficient SARS-Cov-2 vaccine allocation to states and counties in the USA
Ives, A. R., Bozzuto, C.
10.1101/2021.03.17.21253793 — Posted: 2021-03-17
B.1.1.7 became the dominant variant in Lebanon.
younes, M., Hamze, K., Osman, K. L., Carter, D. P., Pullan, S. T., Caroll, M., Vipond, R. T., Mohamad, N., nassar, h., Ghaddar, M., Makki, M., Nguewa, P., Abdel Sater, f.
10.1101/2021.03.17.21253782 — Posted: 2021-03-17
Can we predict antibody responses in SARS-CoV-2? A cohort analysis.
Gaeddert, M., Kitchen, P., Broger, T., Weber, S., Bartenschlager, R., Plaszczyca, A., Kräusslich, H.-G., Müller, B., Souto-Carneiro, M., Janssen, M., Müller-Tidow, C., Merle, U., Herrmann, Y., Raedeker, L., Sebastian, J., Brindl, N., Starck, T., Denkinger, C. M.
10.1101/2021.03.15.21253267 — Posted: 2021-03-17
An integrated analysis of contact tracing and genomics to assess the efficacy of travel restrictions on SARS-CoV-2 introduction and transmission in England from June to September, 2020
Aggarwal, D., Page, A. J., Schaefer, U., Savva, G. M., Myers, R., Volz, E., Ellaby, N., Platt, S., Groves, N., Gallaghar, E., Tumelty, N. M., Le-Viet, T., Hughes, G. J., Chen, C., Turner, C., Logan, S., Harrison, A., The COVID-19 Genomics UK (COG-UK) Consortium, , Peacock, S. J., Chand, M., Harrison, E. M.
10.1101/2021.03.15.21253590 — Posted: 2021-03-17
Impact of booster COVID-19 vaccine for Moroccan adults: A discrete age-structured model approach
Hammoumi, A., Hmarrass, H., Qesmi, R.
10.1101/2021.03.14.21253555 — Posted: 2021-03-17
Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model
Gog, J. R., Hill, E. M., Danon, L., Thompson, R. N.
10.1101/2021.03.14.21253544 — Posted: 2021-03-17 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).